NCT03360552

Brief Summary

The objective of the present study is to evaluate the effectiveness of a general practitioner (MG) management strategy guided by a multidimensional evaluation on the multidimensional score of fragility of patients with mild to moderately severe dementia, compared to those currently implemented (without the provision of such an assessment). The measurement of the respective effectiveness of the two types of care in primary care will itself be based on a multidimensional evaluation performed independently in the memory center having established the diagnosis of Alzheimer's disease. The secondary objectives are the evaluation of the impact of the strategy on the functional abilities of patients, the incidence of geriatric syndromes, cognitive functions, quality of life of the patient and the burden of the primary caregiver. The efficiency of the strategy will be assessed through a cost-effectiveness analysis. A survey of opinions will also be conducted among primary health care providers, carers and CMs on the implemented system.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 28, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 4, 2017

Completed
1.1 years until next milestone

Study Start

First participant enrolled

January 16, 2019

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
Last Updated

August 24, 2021

Status Verified

August 1, 2021

Enrollment Period

7 years

First QC Date

November 28, 2017

Last Update Submit

August 17, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of multidimensional fragility scores

    The multidimensional evaluation score produced by Nurses in the home of AM patients and passed on to patients' doctors increases decision-making and patient care

    20 months

Study Arms (2)

the multidimensional score of fragility (RAI CA)

EXPERIMENTAL

A general practitioner (MG) management strategy guided by a multidimensional evaluation (RAI-CA) on the multidimensional score of fragility (RAI-HC) of patients with mild to moderately severe dementia.

Other: Multidimensional fragility index questionnaire RAI-Home Care

Usual care

PLACEBO COMPARATOR

support for patients without multidimensional evaluation (RAI-CA)

Other: Usual care

Interventions

Questionnaire for assessing deficits in Alzheimer's disease

the multidimensional score of fragility (RAI CA)

Usual clinical evaluation

Usual care

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients with probable Alzheimer's disease, according to the criteria usually used in memory centers
  • Aged over 64 years with mild to moderately severe dementia syndrome
  • Volunteers for medical follow-up for a period of 20 months; Which the general practitioner attending agrees to participate in the research

You may not qualify if:

  • Patients under 65 years old
  • presenting with early cognitive decline or severe dementia
  • Not meeting the clinical diagnostic criteria for Alzheimer's disease
  • Refusing or unable to sign informed consent to participate
  • Not voluntary for medical follow-up for a period of 20 months
  • Whose general practitioner refuses to participate in the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique Hôpitaux de Marseille

Marseille, 13354, France

RECRUITING

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Central Study Contacts

Mattieu CECCALDI, PU-PH

CONTACT

Jean-Olivier ARNAUD, Director

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2017

First Posted

December 4, 2017

Study Start

January 16, 2019

Primary Completion

January 15, 2026

Study Completion

January 15, 2026

Last Updated

August 24, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations